Colorado Bill Targets Misleading Compounded Weight Loss Drugs (GLP-1s)
Colorado lawmakers are advancing legislation aimed at protecting consumers from potentially harmful and misleading weight loss products, specifically those marketed as compounded medications. The bill, Senate Bill 26-066, seeks to increase oversight of these custom-made drugs, which have seen a surge in popularity alongside newer GLP-1 receptor agonists like Ozempic and Wegovy. The growing demand … Read more